Source: Hematology, Transfusion and Cell Therapy. Conference titles: Congresso Brasileiro de Hematologia, Hemoterapia e Terapia Celular (HemoPlay 2020). Unidades: FCFRP, FMRP
Subjects: LEUCEMIA, LINFOMA, LINFÓCITOS B, LINFÓCITOS T
ABNT
SILVESTRE, Renata Nacasaki et al. Engineered CD19-CAR NK cells as an off-the-shelf alternative to B cell leukemia and lymphoma treatment. Hematology, Transfusion and Cell Therapy. São Paulo: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.htct.2020.10.703. Acesso em: 01 set. 2024. , 2020APA
Silvestre, R. N., Eitler, J., Fantacini, D. M. C., Farias, K. C. R. M. de, Swiech, K., Covas, D. T., et al. (2020). Engineered CD19-CAR NK cells as an off-the-shelf alternative to B cell leukemia and lymphoma treatment. Hematology, Transfusion and Cell Therapy. São Paulo: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. doi:10.1016/j.htct.2020.10.703NLM
Silvestre RN, Eitler J, Fantacini DMC, Farias KCRM de, Swiech K, Covas DT, Tonn T, Picanço-Castro V. Engineered CD19-CAR NK cells as an off-the-shelf alternative to B cell leukemia and lymphoma treatment [Internet]. Hematology, Transfusion and Cell Therapy. 2020 ; 42 S418.[citado 2024 set. 01 ] Available from: https://doi.org/10.1016/j.htct.2020.10.703Vancouver
Silvestre RN, Eitler J, Fantacini DMC, Farias KCRM de, Swiech K, Covas DT, Tonn T, Picanço-Castro V. Engineered CD19-CAR NK cells as an off-the-shelf alternative to B cell leukemia and lymphoma treatment [Internet]. Hematology, Transfusion and Cell Therapy. 2020 ; 42 S418.[citado 2024 set. 01 ] Available from: https://doi.org/10.1016/j.htct.2020.10.703